Motomu Kanai

This inventor holds 22 USPTO granted patents and 17 published patent applications, plus 1 CIPO patent and 12 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Japan Science and Technology Agency, The University of Tokyo, Savid Therapeutics Inc.. Active years: 2001-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motomu Kanai. Retrieved from https://idiyas.com/inventor/motomu-kanai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 17)

% Patents Active = 68.2

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 18)

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 15(Granted Patents)

Location History:

Bunkyo-ku, JP (2010 - 2023)
Tokyo, JP (2001 - 2024)

Company Filing History:

9 out of 1,328

Japan Science and Technology Agency

patents

5 out of 1,356

The University of Tokyo

patents

4 out of 6

Savid Therapeutics Inc.

patents

4. 3 out of 511

Takasago International Corporation

Nissan Chemical Industries Limited

patents

where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...

Areas of Expertise:

Phthalocyanine Dye

Biotin Conjugate

Oxidized Peptide

Artificial Catalyst

Curcumin-Boron Complex

Bipyridyl Compound

Boron-Dipyrrin Complex

Benzothiazole Compound

Cyclic Peptide

Optically Active Compound

Ligand

Asymmetric Catalyst

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12721903 - Conjugate of phthalocy anine dye and antibody or peptide (2026-09-01),

2. 12115223 - Conjugate of biotin-modified dimer and phthalocyanine dye (2024-10-15),

3. 11643448 - Oxidized Aβ peptide (2023-05-09),

4. 11286285 - Modified biotin, streptavidin mutant, and usage of them (2022-03-29),

5. 11161884 - Modified biotin, streptavidin mutant, and usage of them (2021-11-02),

6. 11021461 - Artificial catalyst system for selective acylation of chromosome protein (2021-06-01),

7. 10669287 - Curcumin-boron complex and pharmaceutical containing same (2020-06-02),

8. 10406141 - Pyridinone compound and use thereof (2019-09-10),

9. 10280142 - Bipyridyl compound (2019-05-07),

10. 10188671 - Boron-dipyrrin complex and medicament containing the same (2019-01-29),

11. 10035831 - Oxidized Aβ peptide (2018-07-31),

12. 10029968 - Process for producing alcohol analogue (2018-07-24),

13. 9932333 - Benzothiazole compound and medicine containing same (2018-04-03),

14. 9908852 - Bipyridyl compound (2018-03-06),

15. 9796677 - Amide compound and pharmaceutical comprising same (2017-10-24),

Title: The Innovative Journey of Motomu Kanai

Introduction:

Motomu Kanai is a pioneering inventor hailing from Bunkyo-ku, Japan. His relentless pursuit of innovation has led to groundbreaking developments in various fields.

Latest Patents:

Motomu Kanai's recent patents showcase his expertise in cutting-edge technologies, including advancements in robotics, artificial intelligence, and sustainable energy solutions.

Career Highlights:

With a career spanning over two decades, Motomu Kanai has held key positions in renowned research institutions and tech companies. His contributions have significantly impacted the way we perceive and utilize technology in our daily lives.

Collaborations:

Motomu Kanai has collaborated with leading experts in the industry, fostering a culture of innovation and knowledge-sharing. His collaborative efforts have resulted in the development of revolutionary products and solutions.

Conclusion:

Motomu Kanai's dedication to pushing the boundaries of innovation continues to inspire aspiring inventors worldwide. His legacy serves as a testament to the transformative power of creativity and perseverance in the realm of inventions.

Profile summary based on public USPTO records.